#vaccination — Tuesday, August 25, 2026 (3 items)
| 0 | ℹ |
Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-08-25 | #vaccination #pregnancy #immunogenicity #hiv #streptococcus | |
| 0 | ℹ |
Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study.
(linkinghub.elsevier.com)
|
The Lancet 2026-08-25 | #vaccination #serology #immunogenicity #filovirus #cross-reactivity | |
| 0 | ℹ |
Multi-source agent-based modeling to optimize influenza mitigation strategies in Hong Kong.
(nature.com)
|
Nature Communications 2026-08-25 | #influenza #modeling #vaccination #epidemiology #intervention |